Koarai, Akira https://orcid.org/0000-0001-9147-4225
Yamada, Mitsuhiro
Ichikawa, Tomohiro
Fujino, Naoya
Kawayama, Tomotaka
Sugiura, Hisatoshi
Article History
Received: 12 February 2021
Accepted: 10 June 2021
First Online: 22 June 2021
Declarations
:
: Not applicable.
: Not applicable.
: AK reports grants from Novartis, personal fees for lectures from Astellas, AstraZeneca, Kyorin, Novartis, Sanofi and Taiho, and personal fees for lectures and consulting from Boehringer Ingelheim and GlaxoSmithKline, outside the submitted work. MY reports grants from Japan Society for the Promotion of Science and Novartis, and personal fees for lectures from AstraZeneca, Meiji Seika Pharma, Novartis, Daiichi Sankyo, Sanofi and Boehringer Ingelheim, outside the submitted work. TI has nothing to disclose. NF reports personal fees for lectures from AstraZeneca, outside the submitted work. TK reports grants from Novartis, and personal fees for lectures from AstraZeneca, Boehringer Ingelheim, Meiji Seika Pharma and GlaxoSmithKline, outside the submitted work. HS reports grants from MSD and Novartis, personal fees for lectures from Astellas, Kyorin, Novartis and Sanofi, and personal fees for lectures and consulting from AstraZeneca, Boehringer Ingelheim and GlaxoSmithKline, outside the submitted work.